| Coverage with evidence development for pharmaceuticals: a policy in evolution? | |
| | |
MedLine Citation:
|
PMID: 21563627 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Coverage with evidence development (CED) has been developed as a response to the uncertainty in evidence when new technologies, including pharmaceuticals, are introduced into the market. Rather than deny coverage for these technologies or grant them unlimited coverage, CED attempts to ensure that patients' access to new medications is not prevented but is managed in a coordinated way, while also generating additional evidence to reduce any uncertainty about the value of the medications. CED projects are currently operating in Australia, Canada, the United Kingdom, and the United States. However, decision-making about these projects is haphazard, and basic information about the projects is not publicly available. As a new policy development there are many unanswered policy questions, and no organized comprehensive strategy seems to be in place in any country for resolving these questions. Until these policy issues have been addressed, CED will have difficulty achieving its potential. |
| | |
Authors:
|
Joel Lexchin |
Related Documents
:
|
8059497 - Life-threatening conditions associated with male infertility. 10576107 - Biomarker approach to evaluating the impact of scientific stations on the antarctic env... 4432067 - Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphrodi... 10932677 - Clinical evaluation of the obese patient. 4929367 - Controlled trial of azathioprine and prednisone in chronic renal disease. report by med... 21068537 - Appropriate vte prophylaxis is associated with lower direct medical costs. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International journal of health services : planning, administration, evaluation Volume: 41 ISSN: 0020-7314 ISO Abbreviation: Int J Health Serv Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-05-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1305035 Medline TA: Int J Health Serv Country: United States |
Other Details:
|
Languages: eng Pagination: 337-54 Citation Subset: IM |
Affiliation:
|
School of Health Policy and Management, York University, Toronto, ON, Canada. jlexchin@yorku.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: New wine in an old bottle: does alienation provide an explanation of the origins of physician discon...
Next Document: The Colombian health insurance system and its effect on access to health care.